[go: up one dir, main page]

ATE447025T1 - Ionenkanalaktivität hemmende niedrigmolekulare peptide - Google Patents

Ionenkanalaktivität hemmende niedrigmolekulare peptide

Info

Publication number
ATE447025T1
ATE447025T1 AT04723309T AT04723309T ATE447025T1 AT E447025 T1 ATE447025 T1 AT E447025T1 AT 04723309 T AT04723309 T AT 04723309T AT 04723309 T AT04723309 T AT 04723309T AT E447025 T1 ATE447025 T1 AT E447025T1
Authority
AT
Austria
Prior art keywords
low molecular
ion channel
polypeptides
channel activity
molecular peptides
Prior art date
Application number
AT04723309T
Other languages
English (en)
Inventor
Takane Yokotagawa
Masahiro Sokabe
Toshio Furuya
Original Assignee
Pharmadesign Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmadesign Inc filed Critical Pharmadesign Inc
Application granted granted Critical
Publication of ATE447025T1 publication Critical patent/ATE447025T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04723309T 2003-03-26 2004-03-25 Ionenkanalaktivität hemmende niedrigmolekulare peptide ATE447025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003085666 2003-03-26
PCT/JP2004/004190 WO2004085647A1 (ja) 2003-03-26 2004-03-25 イオンチャネルの活性を阻害する低分子ペプチド

Publications (1)

Publication Number Publication Date
ATE447025T1 true ATE447025T1 (de) 2009-11-15

Family

ID=33095036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04723309T ATE447025T1 (de) 2003-03-26 2004-03-25 Ionenkanalaktivität hemmende niedrigmolekulare peptide

Country Status (6)

Country Link
US (2) US7396816B2 (de)
EP (1) EP1609861B1 (de)
JP (1) JP4488522B2 (de)
AT (1) ATE447025T1 (de)
DE (1) DE602004023827D1 (de)
WO (1) WO2004085647A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320842D0 (en) * 2003-09-05 2003-10-08 Ionix Pharmaceuticals Ltd Ion channel modulators
WO2006014493A2 (en) * 2004-07-07 2006-02-09 The Research Foundation Of State University Of New York Stor Mechanically activated channel blocker
JP4654432B2 (ja) * 2004-11-08 2011-03-23 国立大学法人名古屋大学 機械受容(StretchActivated)チャネルの活性化抑制剤
PL213159B1 (pl) 2010-04-23 2013-01-31 Inst Biolog Doswiadczalnej Im Marcelego Nenckiego Pan Zmutowane szczepy Escherichia coli, sposób testowania potencjalnych zwiazków antybakteryjnych wykorzystujacy te szczepy oraz zestaw do testowania
US9211313B2 (en) 2011-01-14 2015-12-15 The Research Foundation Of State University Of New York Methods and compound to inhibit Ca2+ permeable cation conductance
EA201391331A1 (ru) 2011-03-16 2014-02-28 Эмджен Инк. Активные и селективные ингибиторы nav1.3 и nav1.7
JP2014084283A (ja) * 2012-10-19 2014-05-12 Univ Of Yamanashi 排尿障害治療薬
US10344060B2 (en) 2013-03-12 2019-07-09 Amgen Inc. Potent and selective inhibitors of Nav1.7
AR096927A1 (es) 2013-03-12 2016-02-10 Amgen Inc INHIBIDORES POTENTES Y SELECTIVOS DE NaV1.7
CN106632603B (zh) * 2016-12-09 2019-05-17 唐琼瑶 一组肽及其药物组合物和应用
US11612634B2 (en) 2020-12-11 2023-03-28 Xuzhou Medical University Pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001249925A1 (en) * 2000-04-07 2001-10-23 The Research Foundation Of State University Of New York Mechanically activated channel blocker

Also Published As

Publication number Publication date
JP4488522B2 (ja) 2010-06-23
EP1609861B1 (de) 2009-10-28
WO2004085647A1 (ja) 2004-10-07
JPWO2004085647A1 (ja) 2006-08-24
EP1609861A1 (de) 2005-12-28
US20090181899A1 (en) 2009-07-16
US20060229434A1 (en) 2006-10-12
US7396816B2 (en) 2008-07-08
EP1609861A4 (de) 2006-05-31
DE602004023827D1 (de) 2009-12-10

Similar Documents

Publication Publication Date Title
WO2003089457B1 (en) Peptide inhibitors of protein kinase c ϝ for pain management
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
NO20023224L (no) DNA som koder for et biologisk aktivt fragment av baktericid/permeabilitetsökende protein, fremgangsmåte forfremstilling av dette, samt farmasöytisk preparat inneholdendedette
IN2014CN02050A (de)
ATE447025T1 (de) Ionenkanalaktivität hemmende niedrigmolekulare peptide
DE60126966D1 (de) Tgf-beta inhibitoren und methoden
MX2008009493A (es) Peptido novedoso y uso del mismo.
EP1801206A4 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
WO2003078613A3 (de) Serin hydroxymethyltransferase als target für herbizide
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
WO2003040370A1 (fr) Proteines du metabolisme permettant de lutter contre les mauvaises herbes, leurs genes et leur utilisation
DE60127113D1 (de) Gd3 mimetische peptide
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
ATE82984T1 (de) Hemmende peptide.
WO2009020189A1 (ja) 血圧降下剤
DE60225699D1 (de) Nierenspezifischer urattransporter und dessen gen
EP2072524A3 (de) Dipeptide und tripeptide mit anti-inflammatorischer wirkung
WO2004096832A3 (en) Novel antiangiogenic peptides
ATE405827T1 (de) Screening-verfahren
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
WO2003022300A1 (fr) Remedes prophylactiques et curatifs contre les maladies des os et des articulations
WO2005105838A3 (en) Ion channel
ATE235509T1 (de) Peptide zur inhibition von hpv e7 proteinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties